Calder Biosciences
NYC, US · Founded 2018 · 4 employees on LinkedIn · 1 known investors
Calder Biosciences develops protein-based subunit vaccines using its 3D-Vaxlock technology, which uses dityrosine crosslinking to lock immunogens into the shape they hold on a virus surface for improved antibody responses. Its engineered immunogens aim to offer better safety, efficacy, thermostability, and reduced cold chain requirements against infectious diseases.
Founders & leadership
Calder Biosciences was founded in 2018 by Christopher Marshall and Mark A. Yondola.
Investors · 1
Competitors · 1
by search overlapCompanies competing with Calder Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $299.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $2.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $599.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Calder Biosciences do?
- Calder Biosciences develops protein-based subunit vaccines using its 3D-Vaxlock technology, which uses dityrosine crosslinking to lock immunogens into the shape they hold on a virus surface for improved antibody responses. Its engineered immunogens aim to offer better safety, efficacy, thermostability, and reduced cold chain requirements against infectious diseases.
- Who founded Calder Biosciences?
- Calder Biosciences was founded by Christopher Marshall, Mark A. Yondola in 2018.
- Who are Calder Biosciences's investors?
- Calder Biosciences's investors include SOSV.
- Where is Calder Biosciences headquartered?
- Calder Biosciences is headquartered in NYC, US.